Bergström, H.; Helde Frankling, M.; Klasson, C.; Lövgren Sandblom, A.; Diczfalusy, U.; Björkhem-Bergman, L.
CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women. Cancers 2021, 13, 4689.
https://doi.org/10.3390/cancers13184689
AMA Style
Bergström H, Helde Frankling M, Klasson C, Lövgren Sandblom A, Diczfalusy U, Björkhem-Bergman L.
CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women. Cancers. 2021; 13(18):4689.
https://doi.org/10.3390/cancers13184689
Chicago/Turabian Style
Bergström, Helena, Maria Helde Frankling, Caritha Klasson, Anita Lövgren Sandblom, Ulf Diczfalusy, and Linda Björkhem-Bergman.
2021. "CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women" Cancers 13, no. 18: 4689.
https://doi.org/10.3390/cancers13184689
APA Style
Bergström, H., Helde Frankling, M., Klasson, C., Lövgren Sandblom, A., Diczfalusy, U., & Björkhem-Bergman, L.
(2021). CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women. Cancers, 13(18), 4689.
https://doi.org/10.3390/cancers13184689